2 doctors presenting and participating in Q&A put the snippet of the top line PASI75 data in perspective.
They view the full package of efficacy and safety profile as significant.
I can't do it justice in a few line post. A must listen and makes it clear why Celgene views apremilast as a blockbuster in Psoriasis AND PsA.
Any significant dip provides a buying opp, imo.